CACNA1D and prostate carcinoma: A study of CACNA1D in prostate cancer in the ONCOMINE database (Chen et al. 2014a) revealed its significant overexpression in cancer tissues compared with normal prostate, consistent with findings of CACNAID mRNA and CaV1.3 protein expression in prostate cancer cell lines.